The ADVIA2120i parameter Revised %MICRO is a surrogate marker of schistocyte formation after hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

The ADVIA2120i parameter Revised %MICRO is a surrogate marker of schistocyte formation after hematopoietic stem cell transplantation

Published:2020 Issue:3.4 Volume:67 Page:250-254
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Ikegame Akishige¹,Inoue Yusuke¹,Hata Makoto¹,Sugasaki Motoki¹,Yoshida Hiroko¹,Ogasa Satiko,Nakao Takayuki¹,Ikegame Kazuhiro²,Fujii Shiro³,Shibata Eriko⁴,Nagai Kojiro⁴,Takayama Tetsuji⁴,Abe Masahiro³

Affiliation:

1. Division of Medical Technology, Tokushima University Hospital, Tokushima, Japan

2. Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan

3. Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

4. Clinical Laboratory, Tokushima University Hospital, Tokushima, Japan

Publisher

University of Tokushima Faculty of Medicine

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/67/3.4/67_250/_pdf

Reference18 articles.

1. 1. Powles RL, Clink HM, Spence D, Morgenstern G, Watson JG, Selby PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawler SD, Kay HE, Lawson D, McElwain TJ, Alexander P : Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1 : 327-329, 1980

2. 2. Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K, Ohta K, Hino M : Risk factor analysis for thrombotic microangiopathy after reduced intensity or myeloablative allogeneic hematopoietic stem cell transplantation. Am J Hematol 81 : 525-531, 2006

3. 3. Roy V, Rizvi MA, Vesely SK, George JN : Thrombotic thrombocytopenic pur-pura-like syndromes following bone marrow transplantation : an analysis of associated con-ditions and clinical outcomes. Bone Marrow Transplant 27 : 641-646, 2001

4. 4. Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, Ferrara J, Soiffer R, Giralt S : Blood and marrow transplant clinical trials network toxicity committee consensus summary : thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11 : 571-575, 2005

5. 5. Zomas A, Saso R, Powles R, Mackay H, Singhal S, Treleaven J, Mehta J : Red cell fragmentation (schistocytosis) after bone marrow transplantation. Bone Marrow Transplant 22 : 777-780, 1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schistocyte detection in artificial intelligence age;International Journal of Laboratory Hematology;2024-03-12

2. Morphological abnormalities of erythrocytes and platelets – selected issues;Diagnostyka Laboratoryjna;2022-08-23

3. 2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions;International Journal of Laboratory Hematology;2021-08-24